In 2003, an international working group last reported on recommendations for diagnosis,
response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that …

Although improvement in outcomes has occurred in younger adults with acute myeloid
leukemia (AML) during the past 4 decades, progress in older adults has been much less …

A sequential regimen of chemotherapy, reduced-intensity conditioning (RIC) for allogeneic
stem cell transplantation (SCT), and prophylactic donor lymphocyte transfusion (pDLT) was …

Background: Acute myeloid leukemia (AML) is a clonal disease characterized by the
proliferation and accumulation of myeloid progenitor cells in the bone marrow, which …

Abstract Treatment options for adults with primary refractory acute myeloid leukaemia (PREF
AML) are extremely limited. Although sibling allogeneic stem cell transplantation can result …

Primary refractory or relapsed acute myeloid leukemia is associated with a dismal
prognosis. Allogeneic stem cell transplantation is the only therapeutic option that offers …

The article presents several guidelines on the management of acute myeloid leukemia in
adults, in London, England. These guidelines were based on the presentation of patients …

Up to 30% of adults with acute myeloid leukemia fail to achieve a complete remission after
induction chemotherapy-termed primary refractory acute myeloid leukemia. There is no …

The optimum chemotherapy schedule for reinduction of patients with high-risk acute myeloid
leukemia (relapsed, resistant/refractory, or adverse genetic disease) is uncertain. The MRC …

Allogeneic hematopoietic stem cell transplantation (alloHSCT) is increasingly being used for
treatment of hematologic malignancies, and the immunologic graft-versus-tumor effect (GVT) …